Moran-Gates T - Search Results

1

Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs.

Ardayfio PA, Leung A, Park J, Hwang DY, Moran-Gates T, Choi YK, Carlezon WA Jr, Tarazi FI, Kim KS. Ardayfio PA, et al. Among authors: moran gates t. Neuroscience. 2010 Mar 17;166(2):391-6. doi: 10.1016/j.neuroscience.2009.12.033. Epub 2009 Dec 22. Neuroscience. 2010. PMID: 20026251 Free PMC article.

2

3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.

Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, Chesselet MF, Kim KS. Hwang DY, et al. J Neurosci. 2005 Feb 23;25(8):2132-7. doi: 10.1523/JNEUROSCI.3718-04.2005. J Neurosci. 2005. PMID: 15728853 Free PMC article.

3

Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.

Moran-Gates T, Massari C, Graulich A, Liégeois JF, Tarazi FI. Moran-Gates T, et al. J Neurosci Res. 2006 Aug 15;84(3):675-82. doi: 10.1002/jnr.20972. J Neurosci Res. 2006. PMID: 16810690

4

Long-term effects of JL 13, a potential atypical antipsychotic, on ionotropic glutamate receptors.

Tarazi FI, Moran-Gates T, Gardner MP, Graulich A, Lamy C, Liégeois JF. Tarazi FI, et al. Among authors: moran gates t. J Mol Neurosci. 2007;32(3):192-8. doi: 10.1007/s12031-007-0034-3. J Mol Neurosci. 2007. PMID: 17873364

5

Asenapine induces differential regional effects on serotonin receptor subtypes.

Tarazi FI, Moran-Gates T, Wong EH, Henry B, Shahid M. Tarazi FI, et al. Among authors: moran gates t. J Psychopharmacol. 2010 Mar;24(3):341-8. doi: 10.1177/0269881108095704. Epub 2008 Aug 21. J Psychopharmacol. 2010. PMID: 18719049

6

Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.

Moran-Gates T, Zhang K, Baldessarini RJ, Tarazi FI. Moran-Gates T, et al. Int J Neuropsychopharmacol. 2005 Sep;8(3):439-44. doi: 10.1017/S1461145705005249. Epub 2005 Apr 7. Int J Neuropsychopharmacol. 2005. PMID: 15817135 Free article.

7

Repeated antipsychotic drug exposure in developing rats: dopamine receptor effects.

Moran-Gates T, Gan L, Park YS, Zhang K, Baldessarini RJ, Tarazi FI. Moran-Gates T, et al. Synapse. 2006 Feb;59(2):92-100. doi: 10.1002/syn.20220. Synapse. 2006. PMID: 16270300

8

Effects of risperidone on dopamine receptor subtypes in developing rat brain.

Moran-Gates T, Grady C, Shik Park Y, Baldessarini RJ, Tarazi FI. Moran-Gates T, et al. Eur Neuropsychopharmacol. 2007 May-Jun;17(6-7):448-55. doi: 10.1016/j.euroneuro.2006.10.004. Epub 2006 Dec 18. Eur Neuropsychopharmacol. 2007. PMID: 17175142 Free PMC article.

9

Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats.

Choi YK, Moran-Gates T, Gardner MP, Tarazi FI. Choi YK, et al. Among authors: moran gates t. Eur Neuropsychopharmacol. 2010 Mar;20(3):187-94. doi: 10.1016/j.euroneuro.2009.09.002. Epub 2009 Oct 29. Eur Neuropsychopharmacol. 2010. PMID: 19875272 Free PMC article.

10

Differential regional and dose-related effects of asenapine on dopamine receptor subtypes.

Tarazi FI, Moran-Gates T, Wong EH, Henry B, Shahid M. Tarazi FI, et al. Among authors: moran gates t. Psychopharmacology (Berl). 2008 May;198(1):103-11. doi: 10.1007/s00213-008-1098-7. Epub 2008 Feb 24. Psychopharmacology (Berl). 2008. PMID: 18297468

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters